NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, RUSSIA, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A BREACH OF THE RELEVANT SECURITIES LAWS OF SUCH JURISDICTION.
This Announcement does not constitute a prospectus or offering memorandum or an offer in respect of any securities and is not intended to provide the basis for any investment decision in respect of Deltex Medical Group plc or other evaluation of any securities of Deltex Medical Group plc or any other entity and should not be considered as a recommendation that any investor should subscribe for or purchase any such securities.
9 February 2018
Deltex Medical Group plc
("Deltex" or the "Company")
Result of General Meeting
On 24 January 2018, the Company published its shareholder circular (the "Circular") in connection with the Capital Raising. The Capital Raising was conditional upon, amongst other things, the passing of the Resolution at the General Meeting.
Deltex is pleased to announce that the Resolution proposed at the General Meeting held earlier today was duly passed by Shareholders.
The Capital Raising remains conditional upon Admission.
Application has been made for the admission of the Placing Shares, the Subscription Shares and the Offer Shares to trading on AIM. In addition, as announced earlier today an additional 8.65 million Ordinary Shares are to be issued to existing shareholders to reduce the level of scale back under the Offer. The total number of shares to be issued as a result of the Capital Raising and the issue of the additional Ordinary Shares is 176.65 million. The issue of the Ordinary Shares is conditional on Admission which is expected to become effective, and dealings in these Ordinary Shares will commence at, 8.00 a.m. on 12 February 2018.
Following Admission, the total number of Ordinary Shares in issue with voting rights will be 489,863,367 Ordinary Shares. Shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.
Capitalised terms used in this announcement shall have the same meanings given to them in the Circular.
For further information please contact:
Deltex Medical Group plc
01243 774 837
Arden Partners plc
020 7614 5900
Turner Pope Investments (TPI) Ltd
0203 621 4120
IFC Advisory Ltd
0203 934 6634
This information is provided by RNS